Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression
IntroductionCartilage Oligomeric Matrix Protein (COMP) is an oncogenic protein that has been associated with a decrease in infiltrating T-cells in periampullary adenocarcinoma. This study aimed to investigate whether this is also the case for colorectal cancer (CRC) and to evaluate the relationship...
Main Authors: | Anna M. Blom, Chrysostomi Gialeli, Catharina Hagerling, Jonna Berntsson, Karin Jirström, Konstantinos S. Papadakos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1167659/full |
Similar Items
-
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition
by: Gilar Gorji-Bahri, et al.
Published: (2024-04-01) -
Serum cartilage oligomeric matrix protein is decreased in patients with pulmonary hypertension: a potential protective factor
by: Dan‐dan Chen, et al.
Published: (2021-10-01) -
Joint remodeling outcome of serum levels of Dickkopf-1 (DKK1), cartilage oligomeric matrix protein (COMP), and C-telopeptide of type II collagen (CTXII) in rheumatoid arthritis
by: Naglaa Idriss, et al.
Published: (2020-04-01) -
Cartilage Oligomeric Matrix Protein - inflammation biomarker in knee osteoarthritis
by: Sandra Živanović, et al.
Published: (2011-02-01) -
Early Resveratrol Treatment Mitigates Joint Degeneration and Dampens Pain in a Mouse Model of Pseudoachondroplasia (PSACH)
by: Jacqueline T. Hecht, et al.
Published: (2023-10-01)